newsfilter
← Latest News
GlobeNewswire·

Zogenix to Participate in the BofA Securities SMID Cap 2H21 Ideas Conference

EMERYVILLE, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Zogenix (NASDAQ:ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, today announced that Stephen J. Farr, Ph.D., President and Chief Executive Officer